Scotts Miracle-Gro names Prathima Hegde as CIO
Bitget2026/10/06 20:07Scotts Miracle-Gro named Prathima Hegde senior vice president, chief information officer. Role covers enterprise IT, technology modernization, AI integration, digital capabilities, operational excellence, SAP S/4HANA implementation. Hegde most recently served as CIO of Del Monte Foods, leading cloud modernization, data analytics, AI initiatives. Earlier roles include head of corporate applications at Tropicana Brands Group, senior IT positions at Adtalem Global Education, Abbott Laboratories. Hegde reports to President and CEO Nate Baxter as a member of the leadership team. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Scotts Miracle-Gro Company published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610061605PRIMZONEFULLFEED9840775) on October 06, 2026, and is solely responsible for the information contained therein.
- Scotts Miracle-Gro named Prathima Hegde senior vice president, chief information officer.
- Role covers enterprise IT, technology modernization, AI integration, digital capabilities, operational excellence, SAP S/4HANA implementation.
- Hegde most recently served as CIO of Del Monte Foods, leading cloud modernization, data analytics, AI initiatives.
- Earlier roles include head of corporate applications at Tropicana Brands Group, senior IT positions at Adtalem Global Education, Abbott Laboratories.
- Hegde reports to President and CEO Nate Baxter as a member of the leadership team.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go
Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.
RBA Minutes: Case for rates to act promptly to keep inflation expectations anchored
Crypto prices
More
